bioRxivBiochemistryPreprint
Natural naphthoquinones isolated from Lithospermum erythrorhizon suppress dextran sulfate sodium-induced murine experimental colitis
W. X. Sun, H. W. Han, Z. Y. Wang, Z. L. Wen, M. K. Yang, Y. S. Wang, J. Y. Fu, L. Feng, X. H. Xu, T. M. Yin, X. M. Wang, G. H. Lu, J. L. Qi, H. Y. Lin, Y.- H. Yang
Abstract
The purpose of this study was to explore the effects of natural shikonin and its derivatives on mice experimental colitis induced by dextran sulfate sodium, and to investigate the underlying mechanisms in vivo. Our results suggested that, intragastric administration of single compound like shikonin and its derivatives contributed to attenuating symptoms of malignant induced by DSS. Meanwhile, shikonin or its derivatives could also remarkably reduce the disease activity index and histopathological scores, suppress the levels of pro-inflammatory cytokines (including IL-6, IL-1{beta} and TNF-), while increase that of inflammatory cytokine IL-10 in serum. Additionally, both shikonin and alkanin were found to restrain the levels of COX-2, MPO and iNOS in serum and colonic tissues. Moreover, western blotting results demonstrated that shikonin and its derivatives could inhibit the activation of the NLRP3 inflammasome and the NF-{kappa}B signaling pathway, relieve the DSS-induced disruption of colonic epithelial tight junction (TJ) in colonic tissues. Further, docking simulation had been performed to prove that shikonin and its derivatives could bind to the active sites of NLRP3 inflammasome and the NF-{kappa}B to generate an effective inflammatory effect. Taken together, our experimental data can provide some evidence for the potential use of shikonin and its derivatives to treat the inflammatory bowel disease (IBD).
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MG53 Protects Against Intestinal Inflammation by Inhibiting NLRP3 Inflammasome Activation
Zhongguang Li, Zachary D. Dawson, … Jianjie Ma·Frontiers in PharmacologyPeer-reviewed·Mar 18, 2026
- Ameliorative effect of a quinazoline-based bromodomain inhibitor, CN210, on experimentally-induced Crohn's disease-like murine ileitis via inhibition of inflammatory cytokine expression
T. Noguchi, K. Hidaka, … S. Kato·bioRxiv·Jan 24, 2020
- The role of sodium thiocyanate supplementation during dextran sodium sulphate-stimulated experimental colitis
B. Chami, Y. A. Liu, … P. K. Witting·bioRxiv·May 27, 2020
- Pharmacological inhibition of GPR4 remediates intestinal inflammation in a mouse colitis model
E. J. Sanderlin, M. Marie, … L. V. Yang·bioRxiv·Jan 29, 2019
- An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors
R. Singh, V. Rossini, … S. Melgar·bioRxiv·Aug 18, 2022
- Loss of WNT5 Proteins Reprograms Neutrophils in the Spleen to Provide Protection for DSS-Induced Colitis